All News

Medicare's new payment formula is set to begin in 2019. The problem is no one's agreed on standards for measuring quality or efficiency of patient care.

In collaborations with 14 cancer centers throughout the country, IBM will apply Watson Genomic Analytics, a cloud-based service, to implement evidence-based treatment decisions in oncology.

The White House is moving to address 2 of the most common consumer complaints about the sale of health insurance under the Affordable Care Act: that doctor directories are inaccurate, and that patients are hit with unexpected bills for costs not covered by insurance.

There's been a big increase in hepatitis C across central Appalachia, especially rural parts of the region, the CDC reported Thursday. That only stands to reason, because young people in that part of the country are injecting heroin and other opioids at epidemic rates.

A one-minute look at managed care news during the week of May 4, 2015, including global cancer drug spend, movements in telehealth, and changing behavior to reverse poor health.

The average per capita spending difference between people with and without diabetes was $10,310 from 2009 to 2013, according to a new report from the Health Care Cost Institute.

It's an incorrect, but convenient, shorthand to say that the Affordable Care Act establishes state-based health insurance markets. Actually, the markets are finer grained than that.

A year and a half ago, Silicon Valley venture capitalist Vinod Khosla made headlines when he stated at a conference that in the next decade "data science and software will do more for medicine than all of the biological sciences together."

Overall, regular breast, cervical, and colorectal cancer screening was below target in 2013, according to a new report from the CDC. In fact, researchers found overall screening in these 3 areas showed no improvements from 2010 to 2013.

The addition by the World Health Organization follows requests by consumer groups for the agency to widen its list to include some of the latest treatments carrying high price tags.

The Roswell Park pathology team reviewed 500 breast core biopsy cases provided by referring institutions in a single calendar year and found that 8% of the cases had a major discordance and 13% had a minor discordance, especially with respect to interpreting biomarkers that determine prognosis and therapeutic options.

Senate Democrats seek to limit profits on Medicaid contractors and included a provision that would bar savings by cutting providers' fees.

Amarin's action has initiated a debate on whether the FDA's authority over ensuring the safety and efficacy is being side-stepped.

The appeals court decision has ensured that Novartis cannot bring its biosimilar Zarxio (filgrastim), which provides immune support to cancer patients, to the market at least till June 3.

It is unclear at this time what role President Barack Obama's healthcare law, the Affordable Care Act, played in the slowdown of healthcare spending and how much can be attributed to the Great Recession.

Johnson & Johnson will ask an independent panel to recommend who gets a breakthrough drug that's still under development.

Healthcare billing and payment models must change to reflect the mobile, one-click reality of patients' lives, according to PwC's Health Research Institute. However, healthcare has been slow to evolve.

Designed to improve physician payment, the Medicare Access and CHIP Reauthorization Act of 2015 is a step in the right direction, and certainly better than the alternative, but it's not magic and it's not enough.

Since the introduction of the Oncology Care Model, oncologists have raised numerous questions as they weigh whether to apply for participation.

Behavior, including adherence behavior, are the keys to improving outcome in a variety of diseases. We must rethink our adherence strategy by using Intelligent Engagement to control the plecosystem of adherence technologies.

The study conducted by researchers at Dana-Farber Cancer Institute, and published in JAMA Oncology, found a siginificant increase in progression-free survival in men who initiated statin therapy along with androgen deprivation for their prostate cancer.

Health and Human Services Secretary Sylvia Mathews Burwell yesterday rejected Governor Rick Scott's proposal to extend the current funding mechanism, which this year brought $1.3 billion in federal funds to hospitals that care for high numbers of uninsured patients.

Pharmacy and therapeutic committees view potential cost savings as the most important factor when recommending formulary placement, according to a new survey.

Researchers at Yale found that targeting nominated friends who were key influencers sparked the highest level of adoption for a nutritional program that was a part of their study. Adoption of the program was 12.2% higher through the influencers.

An independent review of Medicare payments reveals that 42% of the healthcare dollars Medicare paid to providers in its fee-for-service program in 2013 were designed to boost the value of care patients receive.

My mission: getting approval for a supply of blood glucose testing strips my endocrinologist recommends, so I can manage my diabetes and maintain my great quality of life.

The Affordable Care Act provided funds for 10 states to experiment with incentive programs in Medicaid. Researchers hope to learn what steps will motivate beneficiaries to take steps to improve their health.

A study conducted at the University of Maryland School of Public Health, published in the journal Health Affairs, evaluated the results of an intervention to connect low-income uninsured and Medicaid patients to a reliable source of primary healthcare.

Although 30-day morbidity and mortality all declined incrementally for terminally ill cancer patients undergoing surgical intervention from 2006-2010, the number of surgeries remains high, according to a study from University of California, Davis Health System.

At a webinar convened by AISHEalth, "Private Exchange Strategies: What's Working Today? What's Next?" Ashish Kaura and Jay Godla, both partners with Strategy&, provided insight into the challenges faced by private exchanges.